- $140.17m
- $126.13m
- $70.39m
Codexis Inc gains on plan to lay off 25% of workforce
Brief: CODEXIS OUTLOOK FY REVENUE USD 30-35 MILLION FROM PRODUCTS
Brief: Codexis Announces Workforce Reduction Of About 25%
Brief: Codexis Announces Enhanced Strategic Focus
Codexis Inc reports results for the quarter ended in March - Earnings Summary
Brief: Codexis Sees FY revenue USD 63-68 million
Codexis Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Codexis Announces Rna Therapeutics Manufacturing Workshop At Tides USA
U.S. RESEARCH ROUNDUP-C4 Therapeutics, Nvidia, WW Grainger
Brief: Codexis And Nestlé Health Science Announce Interim Results From Phase 1 Clinical Trial Of Cdx-7108 For Exocrine Pancreatic Insufficiency
Brief: Codexis Reports Fourth Quarter And Fiscal Year 2022 Financial Results
Codexis Inc reports results for the quarter ended in December - Earnings Summary
Brief: Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Codexis Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Codexis Announces Appointment Of Sri Ryali As Chief Financial Officer
U.S. RESEARCH ROUNDUP- Apple, Dell Technologies, Tesla
Brief: Codexis Announces Appointment Of H. Stewart Parker To Board Of Directors
Brief: Codexis Authorizes Workforce Reduction Of About 18%
Codexis Inc reports results for the quarter ended in September - Earnings Summary